Urokinase (uPA) and tissue (tPA) plasminogen activators released from cancer cells catalyze the proteolytic conversion of plasminogen to plasmin, leading to degradation of the extracellular matrix (ECM), thus facilitating cancer cell invasion [5-8]. The gene discussed is PLAT; the disease is cancer.